Skip to main content
Erschienen in: Current Treatment Options in Cardiovascular Medicine 9/2017

01.09.2017 | Pregnancy and Cardiovascular Disease (N Scott, Section Editor)

Pregnancy in Women with Congenital Heart Disease

verfasst von: Evin Yucel, MD, Doreen DeFaria Yeh, MD

Erschienen in: Current Treatment Options in Cardiovascular Medicine | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Opinion statement

Advances in cardiac surgical interventions in infancy and childhood have led to an increased number of women with congenital heart disease of childbearing age. For these women, individualized preconception counseling and pregnancy planning should be a vital component of their medical management, and presentation for obstetric care may even be an opportunity to re-establish cardiovascular care for patients who have been lost to follow-up. These patients have unique cardiovascular anatomy and physiology, which is dependent upon the surgical intervention they may have undergone during childhood or adolescence. These factors are associated with a variety of long-term complications, and the normal hemodynamic changes of pregnancy may unmask cardiac dysfunction and pose significant risk. Among three published risk assessment algorithms, the World Health Organization classification is the most sensitive in predicting maternal cardiovascular events in this population. Women with simple congenital heart defects generally tolerate pregnancy well and can be cared for in the community with careful monitoring. Conversely, women with complex congenital defects, with or without surgical repair and/or residual defects, should be managed in tertiary care centers under a multidisciplinary team of physicians experienced in adult congenital heart disease and high-risk obstetrics, who collaboratively participate in pregnancy planning, management, and care through childbirth and postpartum. Women who are cyanotic with oxygen saturation less than 85%, have significant pulmonary arterial hypertension of any cause, or have systemic ventricular dysfunction should be counseled to avoid pregnancy due to a very high risk of maternal and fetal mortality.
Literatur
4.
Zurück zum Zitat Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, et al. Pregnancy-related mortality surveillance—United States, 1991–1999. MMWR Surveill Summ. 2003;52(2):1–8.PubMed Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, et al. Pregnancy-related mortality surveillance—United States, 1991–1999. MMWR Surveill Summ. 2003;52(2):1–8.PubMed
6.
Zurück zum Zitat •• Canobbio MM, Warnes CA, Aboulhosn J, Connolly HM, Khanna A, Koos BJ, et al. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circ. 2017; doi:10.1161/CIR.0000000000000458. This is the most recent AHA guidelines on management of pregnancy in patients with complex CHD which includes sections on pregnancy hemodynamics, general principles, and lesion specific management. •• Canobbio MM, Warnes CA, Aboulhosn J, Connolly HM, Khanna A, Koos BJ, et al. Management of pregnancy in patients with complex congenital heart disease: a scientific statement for healthcare professionals from the American Heart Association. Circ. 2017; doi:10.​1161/​CIR.​0000000000000458​. This is the most recent AHA guidelines on management of pregnancy in patients with complex CHD which includes sections on pregnancy hemodynamics, general principles, and lesion specific management.
7.
Zurück zum Zitat European Society of G, Association for European Pediatric C, German Society for Gender M, Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147–3197. doi:10.1093/eurheartj/ehr218. European Society of G, Association for European Pediatric C, German Society for Gender M, Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the management of cardiovascular diseases during pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147–3197. doi:10.​1093/​eurheartj/​ehr218.
8.
Zurück zum Zitat Fujitani S, Baldisseri MR. Hemodynamic assessment in a pregnant and peripartum patient. Crit Care Med. 2005;33(10 Suppl):S354–61.CrossRefPubMed Fujitani S, Baldisseri MR. Hemodynamic assessment in a pregnant and peripartum patient. Crit Care Med. 2005;33(10 Suppl):S354–61.CrossRefPubMed
9.
Zurück zum Zitat Hankins GD, Wendel GD Jr, Leveno KJ, Stoneham J. Myocardial infarction during pregnancy: a review. Obstet Gynecol. 1985;65(1):139–46.PubMed Hankins GD, Wendel GD Jr, Leveno KJ, Stoneham J. Myocardial infarction during pregnancy: a review. Obstet Gynecol. 1985;65(1):139–46.PubMed
10.
Zurück zum Zitat Hansen SL, Clark SL, Foster JC. Active pushing versus passive fetal descent in the second stage of labor: a randomized controlled trial. Obstet Gynecol. 2002;99(1):29–34.PubMed Hansen SL, Clark SL, Foster JC. Active pushing versus passive fetal descent in the second stage of labor: a randomized controlled trial. Obstet Gynecol. 2002;99(1):29–34.PubMed
11.
Zurück zum Zitat Robson SC, Hunter S, Moore M, Dunlop W. Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study. Br J Obstet Gynaecol. 1987;94(11):1028–39.CrossRefPubMed Robson SC, Hunter S, Moore M, Dunlop W. Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study. Br J Obstet Gynaecol. 1987;94(11):1028–39.CrossRefPubMed
13.
Zurück zum Zitat Fredriksen PM, Veldtman G, Hechter S, Therrien J, Chen A, Warsi MA, et al. Aerobic capacity in adults with various congenital heart diseases. The American journal of cardiology. 2001;87(3):310–4.CrossRefPubMed Fredriksen PM, Veldtman G, Hechter S, Therrien J, Chen A, Warsi MA, et al. Aerobic capacity in adults with various congenital heart diseases. The American journal of cardiology. 2001;87(3):310–4.CrossRefPubMed
14.
Zurück zum Zitat Balci A, Sollie-Szarynska KM, van der Bijl AG, Ruys TP, Mulder BJ, Roos-Hesselink JW, et al. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart. 2014;100(17):1373–81. doi:10.1136/heartjnl-2014-305,597.CrossRefPubMed Balci A, Sollie-Szarynska KM, van der Bijl AG, Ruys TP, Mulder BJ, Roos-Hesselink JW, et al. Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease. Heart. 2014;100(17):1373–81. doi:10.​1136/​heartjnl-2014-305,597.CrossRefPubMed
15.
Zurück zum Zitat Burn J, Brennan P, Little J, Holloway S, Coffey R, Somerville J, et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet. 1998;351(9099):311–6.CrossRefPubMed Burn J, Brennan P, Little J, Holloway S, Coffey R, Somerville J, et al. Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. Lancet. 1998;351(9099):311–6.CrossRefPubMed
16.
Zurück zum Zitat Drenthen W, Pieper PG, van der Tuuk K, Roos-Hesselink JW, Voors AA, Mostert B, et al. Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects. Eur Heart J. 2005;26(23):2581–7. doi:10.1093/eurheartj/ehi439.CrossRefPubMed Drenthen W, Pieper PG, van der Tuuk K, Roos-Hesselink JW, Voors AA, Mostert B, et al. Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects. Eur Heart J. 2005;26(23):2581–7. doi:10.​1093/​eurheartj/​ehi439.CrossRefPubMed
18.
Zurück zum Zitat Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol.. 2008;52(23):e143–263. doi:10.1016/j.jacc.2008.10.001. Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease). Developed in collaboration with the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol.. 2008;52(23):e143–263. doi:10.​1016/​j.​jacc.​2008.​10.​001.
19.
20.
Zurück zum Zitat Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace. 2011;13(8):1077–109. doi:10.1093/europace/eur245.CrossRefPubMed Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace. 2011;13(8):1077–109. doi:10.​1093/​europace/​eur245.CrossRefPubMed
21.
Zurück zum Zitat Mahli A, Izdes S, Coskun D. Cardiac operations during pregnancy: review of factors influencing fetal outcome. Ann Thorac Surg. 2000;69(5):1622–6.CrossRefPubMed Mahli A, Izdes S, Coskun D. Cardiac operations during pregnancy: review of factors influencing fetal outcome. Ann Thorac Surg. 2000;69(5):1622–6.CrossRefPubMed
22.
Zurück zum Zitat Myerson SG, Mitchell AR, Ormerod OJ, Banning AP. What is the role of balloon dilatation for severe aortic stenosis during pregnancy? J Heart Valve Dis. 2005;14(2):147–50.PubMed Myerson SG, Mitchell AR, Ormerod OJ, Banning AP. What is the role of balloon dilatation for severe aortic stenosis during pregnancy? J Heart Valve Dis. 2005;14(2):147–50.PubMed
23.
24.
Zurück zum Zitat Beauchesne LM, Connolly HM, Ammash NM, Warnes CA. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol. 2001;38(6):1728–33.CrossRefPubMed Beauchesne LM, Connolly HM, Ammash NM, Warnes CA. Coarctation of the aorta: outcome of pregnancy. J Am Coll Cardiol. 2001;38(6):1728–33.CrossRefPubMed
26.
Zurück zum Zitat Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol. 1995;173(5):1599–606.CrossRefPubMed Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynecol. 1995;173(5):1599–606.CrossRefPubMed
30.
Zurück zum Zitat Sayama S, Takeda N, Iriyama T, Inuzuka R, Maemura S, Fujita D, et al. Peripartum type B aortic dissection in patients with Marfan syndrome who underwent aortic root replacement: a case series study. BJOG. 2017; doi:10.1111/1471–0528.14635. Sayama S, Takeda N, Iriyama T, Inuzuka R, Maemura S, Fujita D, et al. Peripartum type B aortic dissection in patients with Marfan syndrome who underwent aortic root replacement: a case series study. BJOG. 2017; doi:10.​1111/​1471–0528.​14635.
32.
Zurück zum Zitat Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE, Jr. et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology,American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons,and Society for Vascular Medicine. J Am Coll Cardiol 2010;55(14):e27-e129. doi:10.1016/j.jacc.2010.02.015. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE, Jr. et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology,American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons,and Society for Vascular Medicine. J Am Coll Cardiol 2010;55(14):e27-e129. doi:10.​1016/​j.​jacc.​2010.​02.​015.
33.
Zurück zum Zitat Silversides CK, Kiess M, Beauchesne L, Bradley T, Connelly M, Niwa K, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan’s syndrome. Can J Cardiol. 2010;26(3):e80–97.CrossRefPubMedPubMedCentral Silversides CK, Kiess M, Beauchesne L, Bradley T, Connelly M, Niwa K, et al. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan’s syndrome. Can J Cardiol. 2010;26(3):e80–97.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Connolly HM, Warnes CA. Ebstein’s anomaly: outcome of pregnancy. J Am Coll Cardiol. 1994;23(5):1194–8.CrossRefPubMed Connolly HM, Warnes CA. Ebstein’s anomaly: outcome of pregnancy. J Am Coll Cardiol. 1994;23(5):1194–8.CrossRefPubMed
36.
Zurück zum Zitat Katsuragi S, Kamiya C, Yamanaka K, Neki R, Miyoshi T, Iwanaga N, et al. Risk factors for maternal and fetal outcome in pregnancy complicated by Ebstein anomaly. Am J Obstet Gynecol. 2013;209(5):452 e1–6. doi:10.1016/j.ajog.2013.07.005.CrossRef Katsuragi S, Kamiya C, Yamanaka K, Neki R, Miyoshi T, Iwanaga N, et al. Risk factors for maternal and fetal outcome in pregnancy complicated by Ebstein anomaly. Am J Obstet Gynecol. 2013;209(5):452 e1–6. doi:10.​1016/​j.​ajog.​2013.​07.​005.CrossRef
39.
Zurück zum Zitat Greutmann M, Von Klemperer K, Brooks R, Peebles D, O’Brien P, Walker F. Pregnancy outcome in women with congenital heart disease and residual haemodynamic lesions of the right ventricular outflow tract. Eur Heart J. 2010;31(14):1764–70. doi:10.1093/eurheartj/ehq157.CrossRefPubMed Greutmann M, Von Klemperer K, Brooks R, Peebles D, O’Brien P, Walker F. Pregnancy outcome in women with congenital heart disease and residual haemodynamic lesions of the right ventricular outflow tract. Eur Heart J. 2010;31(14):1764–70. doi:10.​1093/​eurheartj/​ehq157.CrossRefPubMed
40.
Zurück zum Zitat Kampman MA, Siegmund AS, Bilardo CM, van Veldhuisen DJ, Balci A, Oudijk MA, et al. Uteroplacental Doppler flow and pregnancy outcome in women with tetralogy of Fallot. Ultrasound Obstet Gynecol. 2017;49(2):231–9. doi:10.1002/uog.15938.CrossRefPubMed Kampman MA, Siegmund AS, Bilardo CM, van Veldhuisen DJ, Balci A, Oudijk MA, et al. Uteroplacental Doppler flow and pregnancy outcome in women with tetralogy of Fallot. Ultrasound Obstet Gynecol. 2017;49(2):231–9. doi:10.​1002/​uog.​15938.CrossRefPubMed
41.
Zurück zum Zitat Warnes CA, Elkayam U. Congenital heart disease and pregnancy. Cardiac problems in pregnancy: diagnosis and management of maternal and fetal disease. 3rd ed. New York: Wiley-Liss; 1998. p. xvii, 773 p. Warnes CA, Elkayam U. Congenital heart disease and pregnancy. Cardiac problems in pregnancy: diagnosis and management of maternal and fetal disease. 3rd ed. New York: Wiley-Liss; 1998. p. xvii, 773 p.
47.
Zurück zum Zitat Booker SNPD. The Fontan Circulation. Contin Educ Anaesth Crit Care Pain. 2008;8(1):26–30.CrossRef Booker SNPD. The Fontan Circulation. Contin Educ Anaesth Crit Care Pain. 2008;8(1):26–30.CrossRef
48.
49.
52.
Metadaten
Titel
Pregnancy in Women with Congenital Heart Disease
verfasst von
Evin Yucel, MD
Doreen DeFaria Yeh, MD
Publikationsdatum
01.09.2017
Verlag
Springer US
Erschienen in
Current Treatment Options in Cardiovascular Medicine / Ausgabe 9/2017
Print ISSN: 1092-8464
Elektronische ISSN: 1534-3189
DOI
https://doi.org/10.1007/s11936-017-0572-0

Weitere Artikel der Ausgabe 9/2017

Current Treatment Options in Cardiovascular Medicine 9/2017 Zur Ausgabe

Pregnancy and Cardiovascular Disease (N Scott, Section Editor)

Preconception Counseling for Women With Cardiac Disease

Pregnancy and Cardiovascular Disease (N Scott, Section Editor)

Spontaneous Coronary Artery Dissection and Pregnancy

Valvular Heart Disease (J Dal-Bianco, Section Editor)

Current Challenges in Translating Tissue-Engineered Heart Valves

Pregnancy and Cardiovascular Disease (N Scott, Section Editor)

Update on Valvular Heart Disease in Pregnancy

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.